Andrew M. Peterson
Papers
1
Total Citations
3
H-Index
1
About
Andrew M. Peterson is a leading surgical oncologist whose research centers on transoral robotic surgery (TORS) for HPV-positive oropharyngeal squamous cell carcinoma, with a particular focus on optimizing treatment for tonsillar cancers. His most-cited work, "Unilateral vs Bilateral Transoral Robotic Surgery for HPV-Positive Tonsillar Squamous Cell Carcinoma" (2025, 3 citations), addresses a critical clinical debate: whether to surgically remove the contralateral, clinically uninvolved tonsil in patients undergoing primary TORS. By providing evidence on the necessity and outcomes of bilateral versus unilateral approaches, Peterson’s research directly informs surgical decision-making, aiming to reduce overtreatment and preserve quality of life without compromising oncologic control. His contributions are pivotal in refining de-escalation strategies for HPV-positive disease, a rapidly growing cancer type with excellent prognosis. With a focus on balancing efficacy and morbidity, Peterson’s work has immediate impact on clinical guidelines and patient care. His studies are essential reading for head and neck surgeons and oncologists navigating the nuances of robotic surgery in the era of HPV-driven oropharyngeal cancer.
Research Focus
Key Achievements
Top Papers
- 1